Quantum BioPharma Ltd.
QNTM
$18.09
$0.0350.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 157.06% | -12.37% | |||
| Depreciation & Amortization | 9.02% | 14.98% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 42.86% | -45.56% | |||
| Operating Income | -42.86% | 45.56% | |||
| Income Before Tax | -11.74% | -60.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.74% | -60.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 214.52% | 70.00% | |||
| Net Income | -7.89% | -60.00% | |||
| EBIT | -42.86% | 45.56% | |||
| EBITDA | -44.20% | 46.68% | |||
| EPS Basic | 11.61% | -28.13% | |||
| Normalized Basic EPS | 16.39% | -14.93% | |||
| EPS Diluted | 11.61% | -28.13% | |||
| Normalized Diluted EPS | 16.39% | -14.93% | |||
| Average Basic Shares Outstanding | 22.06% | 24.89% | |||
| Average Diluted Shares Outstanding | 22.06% | 24.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||